Linbo Wang Selected Research

Pleural Effusion (Pleural Effusions)

1/2021

Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linbo Wang Research Topics

Disease

41	Neoplasms (Cancer) 06/2022 - 11/2005
31	Breast Neoplasms (Breast Cancer) 06/2022 - 07/2009
13	Stomach Neoplasms (Stomach Cancer) 01/2021 - 02/2004
9	Hyperalgesia 10/2008 - 09/2004
8	Pain (Aches) 10/2008 - 09/2004
7	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2008
6	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 11/2005
6	Inflammation (Inflammations) 04/2017 - 09/2004
5	Carcinogenesis 01/2021 - 04/2010
4	Carcinoma (Carcinomatosis) 08/2016 - 08/2010
3	Triple Negative Breast Neoplasms 04/2022 - 01/2020
3	Adenocarcinoma 08/2010 - 11/2009
3	Bone Neoplasms (Bone Cancer) 10/2008 - 11/2005
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Dementia (Dementias) 01/2022 - 04/2016
2	Lung Neoplasms (Lung Cancer) 01/2018 - 08/2016
2	Lymphatic Metastasis 01/2018 - 03/2012
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Diabetes Mellitus 06/2018
1	Premature Cardiac Complexes (Extrasystoles) 01/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2018
1	Neutropenia 01/2018
1	Paralysis (Palsy) 01/2018
1	Aneuploidy (Aneuploid) 01/2018
1	Polyploidy 01/2018
1	Alopecia (Baldness) 01/2018

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2005
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2009
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2009
6	Freund's AdjuvantIBA 04/2008 - 09/2004
5	Pharmaceutical PreparationsIBA 01/2022 - 09/2004
5	Biological ProductsIBA 01/2022 - 04/2010
5	Estrogen ReceptorsIBA 01/2021 - 01/2012
5	Messenger RNA (mRNA)IBA 10/2017 - 11/2007
4	Tamoxifen FDA LinkGeneric 01/2022 - 01/2018
4	AndrogensIBA 02/2021 - 05/2008
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2010
4	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2012
3	Indicators and Reagents (Reagents)IBA 01/2020 - 03/2017
3	Glucose (Dextrose)FDA LinkGeneric 06/2018 - 05/2015
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2022 - 01/2022
2	Glutamine (L-Glutamine)FDA Link 06/2022 - 01/2022
2	Trastuzumab (Herceptin)FDA Link 06/2022 - 01/2018
2	EnzymesIBA 01/2022 - 05/2015
2	Metformin (Glucophage)FDA LinkGeneric 06/2021 - 02/2021
2	IronIBA 06/2021 - 01/2021
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2021 - 01/2021
2	Androgen Receptors (Androgen Receptor)IBA 02/2021 - 05/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2015
2	tacrolimus binding protein 4 (FKBP52)IBA 01/2021 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
2	Long Noncoding RNAIBA 01/2019 - 01/2017
2	Hormones (Hormone)IBA 01/2019 - 12/2009
2	Epirubicin (Ellence)FDA LinkGeneric 01/2018 - 07/2009
2	Matrix Metalloproteinases (MMPs)IBA 10/2017 - 12/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 01/2012
2	CateninsIBA 12/2014 - 10/2013
2	Cadherins (E-Cadherin)IBA 04/2010 - 12/2009
2	Docetaxel (Taxotere)FDA Link 12/2009 - 07/2009
2	Tumor Viral Antigens (Large T Antigen)IBA 12/2009 - 05/2008
2	Opioid Analgesics (Opioids)IBA 10/2008 - 09/2004
2	salicylhydroxamic acid (SHAM)IBA 10/2008 - 11/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2008 - 11/2007
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2008 - 05/2005
1	fascinIBA 01/2022
1	Drug CombinationsIBA 01/2022
1	erastinIBA 01/2022
1	pevonedistatIBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	abirateroneIBA 02/2021
1	enzalutamideIBA 02/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	SaponinsIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	naringeninIBA 01/2021
1	Pimozide (Orap)FDA Link 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Competitive Endogenous RNAIBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 10/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	IodineIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018

Therapy/Procedure

13	Therapeutics 01/2022 - 05/2008
9	Drug Therapy (Chemotherapy) 04/2022 - 07/2009
8	Neoadjuvant Therapy 06/2022 - 01/2012
8	Electroacupuncture 10/2008 - 09/2004
3	Lymph Node Excision (Lymph Node Dissection) 04/2020 - 02/2004
3	Acupuncture Points (Acupuncture Point) 10/2008 - 05/2005
2	Adjuvant Chemotherapy 01/2021 - 01/2018
2	Operative Time 01/2018 - 09/2017
2	Length of Stay 01/2018 - 09/2017
2	Radiotherapy 04/2017 - 01/2013
2	Castration 12/2009 - 05/2008
2	Spinal Injections 10/2008 - 11/2007
1	Immunotherapy 01/2020